Wedbush Upgrades Harpoon Therapeutics (HARP) to Outperform
Tweet
Share
E-mailGet Alerts HARP Hot Sheet
Price: $23.01 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 24 | New: 48
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 24 | New: 48
Join SI Premium – FREE
Wedbush analyst Robert Driscoll upgraded Harpoon Therapeutics (NASDAQ: HARP) from Neutral to Outperform with a price target of $7.00 (from $5.00).
For an analyst ratings summary and ratings history on Harpoon Therapeutics click here. For more ratings news on Harpoon Therapeutics click here.
Shares of Harpoon Therapeutics closed at $2.00 yesterday.
You May Also Be Interested In
- Best Idea Q3 2026: Ryanair (RYAAY) PT Raised to $79 at Bernstein SocGen
- Top Pick ASML Inc. (ASML) PT Raised to $2,623 at Bernstein SocGen Group
- Orange SA (ORA:FP) (ORAN) PT Lowered to EUR16.50 at Barclays
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
